X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (126) 126
infectious diseases (94) 94
index medicus (86) 86
hiv infections - virology (77) 77
hiv-1 - genetics (74) 74
hiv infections - drug therapy (68) 68
virology (67) 67
female (62) 62
hiv (61) 61
male (61) 61
drug resistance (52) 52
adult (48) 48
microbiology (48) 48
genotype (46) 46
hiv-1 - drug effects (46) 46
anti-hiv agents - therapeutic use (45) 45
mutation (42) 42
antiretroviral therapy (39) 39
immunology (39) 39
human immunodeficiency virus--hiv (35) 35
antiviral agents (31) 31
anti-hiv agents - pharmacology (30) 30
middle aged (30) 30
viral load (30) 30
hiv infection (29) 29
hiv-1 - isolation & purification (29) 29
drug-resistance (28) 28
drug therapy (27) 27
therapy (27) 27
hiv-1 - classification (25) 25
viruses (25) 25
drug resistance, viral (24) 24
pharmacology & pharmacy (24) 24
antiretroviral drugs (23) 23
hiv-1 (23) 23
research (23) 23
analysis (22) 22
drug resistance, viral - genetics (22) 22
highly active antiretroviral therapy (21) 21
molecular sequence data (21) 21
infection (20) 20
mutations (20) 20
treatment outcome (20) 20
antiretroviral therapy, highly active (19) 19
immunodeficiency-virus type-1 (19) 19
prevalence (19) 19
rna (19) 19
aids (18) 18
human immunodeficiency virus (18) 18
protease (18) 18
treatment failure (18) 18
protease inhibitors (17) 17
cd4 lymphocyte count (16) 16
hiv protease inhibitors - therapeutic use (16) 16
polymerase chain reaction (16) 16
resistance (16) 16
algorithms (15) 15
drug therapy, combination (15) 15
genetic aspects (15) 15
health aspects (15) 15
hiv infections - epidemiology (15) 15
hiv reverse transcriptase - genetics (15) 15
sequence analysis, dna (15) 15
transmission (15) 15
care and treatment (14) 14
dna (14) 14
hiv protease - genetics (14) 14
hiv-1-infected patients (14) 14
medicine (14) 14
research article (14) 14
retrospective studies (14) 14
rna, viral - blood (14) 14
antiretrovirals (13) 13
genotypes (13) 13
hiv-1 - physiology (13) 13
reverse transcriptase inhibitors - pharmacology (13) 13
reverse transcriptase inhibitors - therapeutic use (13) 13
hiv 1 (12) 12
multidisciplinary sciences (12) 12
patients (12) 12
phylogeny (12) 12
rna, viral - genetics (12) 12
dosage and administration (11) 11
europe (11) 11
hiv infections - immunology (11) 11
hiv protease inhibitors - pharmacology (11) 11
infections (11) 11
virus diseases (11) 11
biotechnology & applied microbiology (10) 10
efficacy (10) 10
epidemiology (10) 10
italy (10) 10
molecular epidemiology (10) 10
reverse-transcriptase (10) 10
science (10) 10
settore med/07 - microbiologia e microbiologia clinica (10) 10
susceptibility (10) 10
acquired immune deficiency syndrome--aids (9) 9
antiretroviral agents (9) 9
cluster analysis (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


AIDS, ISSN 0269-9370, 02/2018, p. 1
Journal Article
MOLECULES, ISSN 1420-3049, 11/2019, Volume 24, Issue 21, p. 3988
The human ATPase/RNA helicase X-linked DEAD-box polypeptide 3 (DDX3X) emerged as a novel therapeutic target in the fight against both infectious diseases and... 
HIV-1 | host proteins | TARGET | antivirals | DDX3X | REPLICATION | HEPATITIS-C VIRUS | BOX RNA HELICASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, MULTIDISCIPLINARY | DISCOVERY | SMALL-MOLECULE INHIBITOR | hiv-1 | ddx3x
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 3/2010, Volume 50, Issue 6, pp. 895 - 897
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 10/2014, Volume 86, Issue 10, pp. 1648 - 1655
Journal Article
by Bertoli, Ada and Sorbo, Maria Chiara and Aragri, Marianna and Lenci, Ilaria and Teti, Elisabetta and Polilli, Ennio and Di Maio, Velia Chiara and Gianserra, Laura and Biliotti, Elisa and Masetti, Chiara and Magni, Carlo F and Babudieri, Sergio and Nicolini, Laura A and Milana, Martina and Cacciatore, Pierluigi and Sarmati, Loredana and Pellicelli, Adriano and Paolucci, Stefania and Craxì, Antonio and Morisco, Filomena and Palitti, Valeria Pace and Siciliano, Massimo and Coppola, Nicola and Iapadre, Nerio and Puoti, Massimo and Rizzardini, Giuliano and Taliani, Gloria and Pasquazzi, Caterina and Andreoni, Massimo and Parruti, Giustino and Angelico, Mario and Perno, Carlo Federico and Cento, Valeria and Ceccherini-Silberstein, Francesca and Andreone, Pietro and Baldanti, Fausto and Barbarini, Giorgio and Boccaccio, Vincenzo and Boglione, Lucio and Bolis, Matteo and Bonora, Stefano and Borghi, Vanni and Brancaccio, Giuseppina and Bruno, Savino and Bruzzone, Bianca and Calvaruso, Vincenza and Caporaso, Nicola and Ciaccio, Antonio and Ciancio, Alessia and Colombatto, Piero and Cozzolongo, Raffaele and D'Ambrosio, Cecilia and D'Ettorre, Gabriella and De Leonardis, Francesco and De Luca, Andrea and Di Biagio, Antonio and Di Perri, Giovanni and Francioso, Simona and Gaeta, Giovanni Battista and Gasbarrini, Antonio and Ghisetti, Valeria and Giorgini, Alessia and Grieco, Antonio and Gubertini, Guido and Gulminetti, Roberto and Lambiase, Lara and Landonio, Simona and Lichtner, Miriam and Maida, Ivana and Marenco, Simona and Marinaro, Letizia and Maserati, Renato and Melis, Michela and Menzaghi, Barbara and Meregalli, Elisa and Micheli, Valeria and Niero, Fosca and Paoloni, Maurizio and Pieri, Alessandro and Rendina, Maria and Romagnoli, Dante and Rossetti, Barbara and Ruggiero, Tina and Sangiovanni, Vincenzo and Starace, Mario and Sticchi, Laura and Tarquini, Pierluigi and Toniutto, Pierluigi and Vullo, Vincenzo and Zazzi, Maurizio and Hcv Virology Italian Resistance Ne and HCV Virology Italian Resistance Network (VIRONET-C)
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 8988 - 11
Natural resistance-associated substitutions (RASs) are reported with highly variable prevalence across different HCV genotypes (GTs). Frequency of natural RASs... 
GLECAPREVIR | TREATMENT-NAIVE | REAL-LIFE | PIBRENTASVIR | CIRRHOSIS | MULTIDISCIPLINARY SCIENCES | SIMEPREVIR PLUS SOFOSBUVIR | RESPONSE RATES | DIRECT-ACTING ANTIVIRALS | 1 INFECTION | OPEN-LABEL | Hepatitis C | Disease resistance | Genotypes
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 01/2020, Volume 75, Issue 1, pp. 252 - 253
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 05/2016, Volume 113, Issue 19, p. 5388
  Targeting a host factor essential for the replication of different viruses but not for the cells offers a higher genetic barrier to the development of... 
Proteins | Toxicity | Viruses | Pharmacology | Kinetics | Ribonucleic acid--RNA | Deoxyribonucleic acid--DNA
Journal Article
PeerJ, ISSN 2167-8359, 2018, Volume 2018, Issue 5, p. e4848
Genotypic drug resistance testing has been an integral part of the clinical management of HIV patients for almost 20 years, not only assisting treatment... 
HIV/AIDS | HIV subtype | Genotypic interpretation system | Drug resistance | Antiretroviral treatment | MULTIDISCIPLINARY SCIENCES | Highly active antiretroviral therapy | Usage | Analysis | HIV (Viruses) | Drug therapy | Geographic information systems
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2017, Volume 12, Issue 6, p. e0178942
Introduction Antiretroviral therapy (ART) has been successfully introduced in low-middle income countries. However an increasing rate of ART failure with... 
VIRAL LOAD | AFRICA | VIROLOGICAL FAILURE | PERFORMANCE | MULTIDISCIPLINARY SCIENCES | ADULTS | SWITCH | CHILDREN | Humans | Male | Nevirapine - therapeutic use | Monitoring, Physiologic | HIV-1 - growth & development | Clinical Decision-Making | Stavudine - therapeutic use | Treatment Failure | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | pol Gene Products, Human Immunodeficiency Virus - genetics | Emtricitabine - therapeutic use | Cross-Sectional Studies | Tenofovir - therapeutic use | HIV-1 - drug effects | HIV Infections - virology | Computational Biology | Tanzania | Genotype | HIV-1 - genetics | Benzoxazines - therapeutic use | HIV-1 - classification | Antiretroviral Therapy, Highly Active | Atazanavir Sulfate - therapeutic use | Drug Resistance, Viral - genetics | HIV Infections - drug therapy | Lopinavir - therapeutic use | Viral Load - drug effects | Prevention | Antiviral agents | Care and treatment | Analysis | DNA polymerases | Dosage and administration | Research | Drug resistance | Drug therapy | HIV infection | Drugs | Therapy | Load distribution | RNA-directed DNA polymerase | Nevirapine | Cross-resistance | Medical services | Switches | Income | Viruses | Stavudine | Criteria | Efavirenz | Accumulation | Guidelines | Gene sequencing | Fragmentation | Tenofovir | Disease resistance | Immunology | Salvage | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Bioinformatics | Monitoring | Failure | Deoxyribonucleic acid--DNA | Emtricitabine | Antiretroviral drugs | Sensitivity analysis | Lopinavir | Lamivudine | Antiretroviral therapy | Amplification | Sensitivity | Algorithms | Inhibitors | Genotyping | Abacavir | Mutation | DNA sequencing | Acquired immune deficiency syndrome | Deoxyribonucleic acid | AIDS | HIV | DNA | Human immunodeficiency virus
Journal Article
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 09/2018
Pre-existence and appearance of resistance associated substitutions limit the efficacy of direct acting antivirals in treatment of hepatitis C. This is the... 
Journal Article
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 9/2005, Volume 192, Issue 6, pp. 958 - 966
Journal Article